{"id":"14c-hec585","_chembl":null,"modality":"Small molecule","_dailymed":null,"_scrapedAt":"2026-03-28T06:31:46.843Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123062,"model":"claude-sonnet-4-5-20250929"},"description":"[14C]-HEC585 is a radiolabeled investigational compound in Phase 1 development by Sunshine Lake Pharma Co., Ltd. The carbon-14 labeling suggests this is likely being studied for absorption, distribution, metabolism, and excretion (ADME) characterization rather than as a therapeutic agent itself.","indications":{"approved":[{"status":"investigational","condition":"ADME study (pharmacokinetic characterization)","patientPopulation":"Healthy volunteers"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"[14C]-HEC585","genericName":"[14C]-HEC585","companyName":"Sunshine Lake Pharma Co., Ltd.","companyId":"sunshine-lake-pharma-co-ltd","firstApprovalDate":"","aiSummary":"","enrichmentLevel":1,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}